We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH TIDM80GT
RNS Number : 8889Z
Dechra Pharmaceuticals PLC
16 January 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0009633180
Issuer Name
DECHRA PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name City of registered office Country of registered office J.P. Morgan Securities plc =========================== ==============================
5. Date on which the threshold was crossed or reached
12-Jan-2024
6. Date on which Issuer notified
16-Jan-2024
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total of both in % Total number of attached to shares through financial (8.A + 8.B) voting rights held (total of 8.A) instruments (total in issuer of 8.B 1 + 8.B 2) Resulting situation on the date on which threshold was crossed or reached 8.271846 0.315854 8.587700 9781946 ====================== ====================== ====================== ====================== Position of previous notification (if applicable) 7.916218 0.297637 8.213855 ====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1) (DTR5.2.1) GB0009633180 9422134 8.271846 ====================== ====================== ====================== ====================== Sub Total 8.A 9422134 8.271846% ============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights instrument that may be acquired if the instrument is exercised/converted Sub Total 8.B1 =========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights instrument period settlement rights Cash-settled Equity Swap 20/02/2024 20/02/2024 Cash 6220 0.005451 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 04/03/2024 04/03/2024 Cash 5090 0.004468 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 27/06/2024 27/06/2024 Cash 880 0.000772 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 31/07/2024 31/07/2024 Cash 39012 0.034249 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 17/10/2024 17/10/2024 Cash 68288 0.059951 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 04/11/2024 04/11/2024 Cash 17 0.000014 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 20/11/2024 20/11/2024 Cash 500 0.000438 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 27/12/2024 27/12/2024 Cash 4313 0.003783 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 22/01/2025 22/01/2025 Cash 202956 0.178178 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 04/02/2025 04/02/2025 Cash 5556 0.004870 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 11/02/2025 11/02/2025 Cash 4200 0.003685 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 17/02/2025 17/02/2025 Cash 15886 0.013944 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 18/06/2027 18/06/2027 Cash 6891 0.006049 ================ ==================== ================== ================== ================== Cash-settled Equity Swap 30/05/2028 30/05/2028 Cash 3 0.000002 ================ ==================== ================== ================== ================== Sub Total 8.B2 359812 0.315854% ================== ==================
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it person undertaking it equals or is through financial equals or is higher higher than the instruments if it than the notifiable notifiable threshold equals or is higher threshold than the notifiable threshold J.P. Morgan JPMorgan Chase & Co. Securities plc 8.245585 8.561439% ======================= ===================== ===================== ====================== JPMorgan Chase & Co. J.P. Morgan Securities LLC ======================= ===================== ===================== ====================== JPMorgan Chase & Co. J.P. Morgan SE ======================= ===================== ===================== ====================== JPMorgan Chase & Co. J.P. Morgan Markets Limited ======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)
JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)
JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
Bear Stearns Irish Holdings LLC (100%)
J.P. MORGAN FINANCIAL INVESTMENTS LIMITED (100%)
J.P. MORGAN MARKETS LIMITED (100%)
12. Date of Completion
16-Jan-2024
13. Place Of Completion
London, United Kingdom
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLUNSSRSAUAAAR
(END) Dow Jones Newswires
January 16, 2024 09:43 ET (14:43 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions